Previous close | 9.90 |
Open | 9.90 |
Bid | 9.86 x 1100 |
Ask | 9.90 x 1100 |
Day's range | 9.88 - 9.90 |
52-week range | 8.30 - 10.41 |
Volume | |
Avg. volume | 142,701 |
Market cap | 284.338M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SAN FRANCISCO, August 01, 2022--Blade Therapeutics to participate in "Drug Development in Pulmonary Medicine" panel discussion on August 9 at the 2022 BTIG Biotechnology Conference
SOUTH SAN FRANCISCO, Calif., May 18, 2022--Blade Therapeutics announces new data from preclinical studies that highlight differentiating characteristics of cudetaxestat in poster at ATS 2022.
SOUTH SAN FRANCISCO, Calif., May 16, 2022--Blade Therapeutics presented data from phase 1 & preclinical DDI studies of cudetaxestat at American Thoracic Society 2022 International Conference